GAMIDA

Israel`s Gamida Cell raises $40 million for bone marrow trial

Israel`s Gamida Cell raises $40 million for bone marrow trial

Published 19/06/2017

Israel's Gamida Cell, which is developing cellular therapies to treat cancer and rare genetic diseases, said on Monday it raised $40 million to finance the advanced trial of its product NiCord to facilitate bone marrow transplants.

[more…]